Premium Information is available for this item - Upgrade for $1 a day
6505-01-051-6515
Usp Levothyroxine Sodium Tablets
6505010516515 010516515 3P1176 SYNTHROID
November 2023
9
Marketplace 6505-01-051-6515
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-051-6515 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-051-6515 RQST Updated Every Day 6505-01-051-6515 RQST NE Related Documents
6505-01-051-6515 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-6515
Usp Levothyroxine Sodium Tablets 010516515 your Account Upgrade 6505-01-051-6515Usp Levothyroxine
Sodium Tablets6505010516515 010516515 3P1176 SYNTHROID Usp Levothyroxine Sodium Tablets 010314739 Upgrade
TABLETS SYNTHROID NDC00048-1140-13 Managed by United States NSN Created on 20 Apr 1984 Data Last Changed
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-177-1970 Usp Levothyroxine Sodium Tablets 011771970 SYNTHROID
TABLETS SYNTHROID NDC00048-1130-03 Managed by United States NSN Created on 25 Aug 1984 Data Last Changed
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-187-7772 Usp Levothyroxine Sodium Tablets 011877772 SYNTHROID
SYNTHROID TABLETS NDC00048-1040-13 3P1033 Managed by United States NSN Created on 4 Feb 1978 Data Last
Upgrade 6505-01-042-9260Usp Levothyroxine Sodium Tablets6505010429260 010429260 NDC00074-6624-19 SYNTHROID
Restrictions 6505-01-051-6515
6505-01-051-6515 is a Usp Levothyroxine Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-051-6515
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
- United States of America (ZZ)
Approved Sources 6505-01-051-6515
- Part Number
- Manufacturer
- Status
- 3P1176
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
- SYNTHROID
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-051-6515
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.300 Milligrams Levothyroxine Sodium Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 5000.000 Tablets
NATO Stock Numbers Related to 6505-01-051-6515
Freight Information 6505-01-051-6515
6505-01-051-6515 has freight characteristics.. 6505-01-051-6515 has a variance between NMFC and UFC when transported by rail and the description should be consulted.